Four Pharma Firms Ditched Medicine Development And Dived Into Crypto

Helius Medical Technologies is the latest medical company to pivot to a digital asset treasury, making it the fourth firm to take a similar step in recent months.

These firms increasingly consider crypto investments a viable alternative to generate the growth their main drug development efforts have struggled to provide.

Helius Medical Technologies officially rebranded as Solana Company this week, becoming the latest medical corporation to pivot its corporate strategy to focus on acquiring digital assets.

Originally a neurotech medical device company, Helius focused on treating different neurological deficits. Its recent name change suggests a strategic shift from its original focus toward an alignment with the Solana blockchain.

As part of this rebranding, Helius is creating a Digital Asset Treasury (DAT) centered around purchases of SOL, the Solana native token. The move follows a recent raise of $500 million dedicated to funding this cryptocurrency treasury strategy.